about
Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparumNovel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease.The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer's disease amyloid-β peptidesThe 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat.Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.A novel approach to inhibit intracellular vitamin B6-dependent enzymes: proof of principle with human and plasmodium ornithine decarboxylase and human histidine decarboxylase.Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.New transition state-based inhibitor for human ornithine decarboxylase inhibits growth of tumor cells.A pharmacological probe identifies cystathionine β-synthase as a new negative regulator for ferroptosisNovel biomimetic affinity ligands for human tissue plasminogen activatorNovel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra RoxbIn Situ Monitoring of p53 Protein and MDM2 Protein Interaction in Single Living Cells Using Single-Molecule Fluorescence SpectroscopyDiscovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine γ-LyaseThe Multiplicity of Polypeptide GalNAc-Transferase: Assays, Inhibitors, and StructuresHorisfieldones A and B, Two Aromatic Ring-Contracted Dimeric Diarylpropanes with Human DOPA Decarboxylase Inhibitory Activity from Horsfieldia kingii
P50
Q28474722-5A6B1C6E-3C06-4E42-947C-D78081DB9E22Q35070249-B7D6EDED-77F7-44F3-8B24-5D1BEBA59015Q36280432-5143AEE6-630C-4ACD-B741-339F945D5805Q37063994-9E67630C-E8E0-4956-AA6F-ECA4E38AFAFFQ37699039-CD5B7BFC-51F9-403D-9255-011B6AC75D1BQ37860042-B995E42B-231F-46C5-8CF3-67B559A3F54FQ39016079-8A5168DF-2D66-42AB-807E-6EBF15EFFA3DQ43125874-1ACC609E-1FA1-4FDB-8684-9CCA8FD51A67Q47613542-78EE70E0-E342-4FE5-9DE3-97E48A3AA07FQ53545893-4C17A0AE-A248-4D73-9BC0-50864928FDB7Q58695733-02B2EA9A-FE0D-4755-BF91-AF4F77CE3211Q79791532-3E3A65F3-F8B1-47B7-9EAF-CE971ABAD1EFQ87179428-2102DCA8-672E-46A7-827C-00FE6CAA56E6Q88405206-DB20FB00-13E9-4BE4-86FF-8BFCB3AAF02BQ90612817-E24E4EB7-898B-4156-96C5-4B162CF01A19Q91173254-08533C0A-B145-4076-AD24-413BE8A16BD1Q91635243-9B6C9D54-F5E2-440B-8204-2B41AE255203
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fang Wu
@ast
Fang Wu
@en
Fang Wu
@es
Fang Wu
@nl
type
label
Fang Wu
@ast
Fang Wu
@en
Fang Wu
@es
Fang Wu
@nl
prefLabel
Fang Wu
@ast
Fang Wu
@en
Fang Wu
@es
Fang Wu
@nl
P106
P31
P496
0000-0002-4194-2243